Since insulin therapy often indicates more advanced disease progression, greater severity, or additional comorbidities, which may lead to a higher risk of intestinal obstruction, and there was no statistically significant difference in intestinal obstruction risk between GLP-1RAs and other anti-diabetic medications (e.g., SGLT2 inhibitors, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors), the observed reduction relative to insulin does not necessarily suggest a protective effect of GLP-1RAs against intestinal obstruction
Is Wegovy covered by health insurance at your clinic
Will Semaglutide affect my weight
Medicaid Coverage Medicaid coverage depends on your state
If your medication appears foggy or contains any visible particles, do not use it and contact your provider or the pharmacy for a replacement